Baird Financial Group’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,823
Closed -$238K 1706
2022
Q2
$238K Buy
5,823
+52
+0.9% +$2.46K ﹤0.01% 1642
2022
Q1
$379K Buy
5,771
+1,094
+23% +$70.9K ﹤0.01% 1531
2021
Q4
$325K Buy
4,677
+70
+2% +$5.09K ﹤0.01% 1637
2021
Q3
$320K Buy
+4,607
New +$355K ﹤0.01% 1646

Other funds holding ATRC

Baird Financial Group's ATRC Position: Q3 2022 in Review

Baird Financial Group sold out of AtriCure (ATRC) in Q3 2022, closing a stake of 5,823 shares — an estimated $238K sold.

Baird Financial Group first reported a position in ATRC in Q3 2021 and held it in 4 quarters. The position peaked at $379K in Q1 2022. 214 funds tracked by Wall St. Rank hold ATRC as of Q3 2022.

  • Baird Financial Group reported no remaining AtriCure position as of Q3 2022 after selling out during the quarter.
  • Baird Financial Group sold 5,823 AtriCure shares in Q3 2022, an estimated $238K.
  • Baird Financial Group first reported a position in AtriCure in Q3 2021 and held it in 4 quarters.
  • Baird Financial Group's AtriCure position peaked at $379K in Q1 2022.
  • 214 funds tracked by Wall St. Rank held AtriCure as of Q3 2022.

Based on Baird Financial Group's 13F filing for Q3 2022, filed 15 Nov 2022.